longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SLDP

SLDP
2.4702.95%( -0.075 )

LongbridgeAI

US Periphery Stocks Catch Bids Amid Broad Market Rotation in 2026

Global Report
Sep 8, 2026 at 09:19 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

A quiet rotation is lifting non-core US equities. Tech infrastructure firms like NetApp posted double-digit revenue growth, while traditional players such as Kraft Heinz accelerate strategic restructuring to defend margins and long-term outlook.

A broad rotation into non-core US equity sectors is gaining momentum, according to multiple analysts and fund managers tracking institutional flows. As high-valuation tech leaders face profit-taking in the third quarter of 2026, capital is increasingly shifting toward data infrastructure, utilities, and consumer goods companies undergoing deep restructuring, lifting year-to-date performance across these peripheral plays.

NetApp (NTAP.US)

NetApp has outperformed its sector peers in recent weeks. The data management firm reported record net revenue of USD 2.03 billion for the first quarter of fiscal 2027, representing a 30% year-over-year jump. All-flash array net revenue hit USD 1.3 billion. The company added roughly 350 AI and data lake modernization deals in the quarter alone, according to internal tracking, prompting management to target 17% median revenue growth for the full fiscal year.

Kraft Heinz (KHC.US)

Shares of Kraft Heinz have stabilized as markets price in its upcoming business overhaul. The company is advancing a strategic split set to close in the second half of 2026, separating into Global Taste Elevation Co. and North American Grocery Co. The restructuring aims to reverse a multi-year sales decline, according to executives, who are also diversifying the portfolio with a recent foray into the alcohol market.

Viatris (SION.US)

Viatris is tracking higher for the year, buoyed by solid product uptake. The healthcare company posted USD 3.8 billion in Q2 2026 revenue, up 5% from the prior year. CEO Scott A. Smith noted that strong first-half execution gave the board confidence to raise the midpoint of its full-year guidance. In late July 2026, the company also secured US FDA approval for its once-weekly contraceptive patch, Gwyn Lo.

Quantum Corporation (QMCO.US)

The storage solutions provider is attempting a turnaround amid recent executive shuffling. In June 2026, Quantum appointed storage veteran Greg Knieriemen as Vice President of Marketing. Although the company filed a Form 12b-25 to delay its financial reporting that same month, analysts suggest its foundational data archiving technology continues to draw interest from enterprise clients.

Zai Lab (ZLAB.US)

Zai Lab has seen its stock rally, outpacing the broader biotech index. The company delivered net product revenues of USD 105.8 million in Q2 2026, an 11% sequential increase. In August 2026, the company and partner argenx reported positive top-line results from a Phase 3 trial of Efgartigimod for autoimmune myositis, while the FDA granted orphan drug designation to its DLL3-targeted ADC, Zoci.

SoftBank Group (SBGSY.US)

SoftBank Group shares have surged recently, driven by a frenzy of Japanese artificial intelligence investments. The technology conglomerate, which controls Arm, committed USD 30 billion to OpenAI in a massive February 2026 funding round, cementing its position as a central player in AI infrastructure. Meanwhile, its SB Energy unit filed a registration statement for an initial public offering in September 2026, according to regulatory filings.

Public Service Enterprise Group (PEG.US)

The New Jersey-based utility operator continues to show defensive resilience. PSEG reported Q2 2026 earnings of USD 0.86 per share, beating consensus estimates of USD 0.80, despite revenue slipping to USD 2.55 billion. The firm established its 2026 earnings guidance at USD 4.280 to USD 4.400 per share, and recently rolled out its GridSmart residential battery pilot program in late August.

Valens Semiconductor (VSTL.US)

The high-performance connectivity chipmaker has enjoyed a strong rebound. Valens generated USD 18.1 million in Q2 2026 revenue, beating the high end of its own guidance. Citing improved visibility, the company raised its full-year 2026 revenue outlook to between USD 78 million and USD 81 million. It also named Dean Martin to lead its automotive business unit starting in September 2026.

nVent Electric (NVT.US)

Shares of nVent Electric advanced after the company announced an aggressive M&A move. On August 24, 2026, nVent reached a definitive agreement to acquire Maverick Power for USD 1.75 billion. This follows a July 2026 board authorization for a new three-year, USD 500 million share repurchase program, moves management expects will rapidly expand its global electrical protection footprint.

Solid Power (SLDP.US)

The solid-state battery developer is recovering from earlier lows, supported by tighter cost controls. Solid Power reported a narrower-than-expected net loss of USD 23.8 million, or USD 0.11 per share, in the second quarter of 2026. Speaking at an automotive conference in August 2026, executives confirmed the company is actively transitioning from R&D into scaled manufacturing.

This article does not constitute investment advice.

Login to unlock4,308characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Mar 17, 2026 at 06:43 AMTransformer supply is in urgent demand! Global shortage may last until 2029
  • Mar 3, 2026 at 09:32 AMStrong demand for AI, and the U.S. is also looking to develop "ultra-high voltage transmission"?

Related Stocks

NetApp

NetApp

USNTAP

+0.44%

Kraft Heinz

Kraft Heinz

USKHC

-1.21%

Sionna Therapeutics

Sionna Therapeutics

USSION

-16.99%